Access to diphtheria antitoxin for therapy and diagnostics

Eurosurveillance

Volumn 19, Issue 24, 2014, Pages

  Both, L ^a   White, J ^a   Mandal, S ^a   Efstratiou, A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA ANTIBODY;

ARTICLE; DIPHTHERIA; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PRACTICE; HUMAN; IMMUNIZATION; IMMUNOPRECIPITATION; NONHUMAN; POLYMERASE CHAIN REACTION; VACCINATION; WORLD HEALTH ORGANIZATION;

BIOLOGICAL PRODUCTS; DIPHTHERIA; DIPHTHERIA ANTITOXIN; DRUGS, ESSENTIAL; EUROPEAN UNION; HEALTH SERVICES ACCESSIBILITY; HUMANS; WORLD HEALTH ORGANIZATION;

EID: 84903140278     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.24.20830     Document Type: Article

References (39)

1. Quick ML, Sutter RW, Kobaidze K, Malakmadze N, Strebel PM, Nakashidze R, et al. Epidemic diphtheria in the Republic of Georgia, 1993-1996: risk factors for fatal outcome among hospitalized patients. J Infect Dis. 2000;181(1):130-7. http://dx.doi.org/10.1086/315550
2. Popovic T, Mazurova IK, Efstratiou A, Vuopio-Varkila J, Reeves MW, De Zoysa A, et al. Molecular epidemiology of diphtheria. J Infect Dis. 2000;181 Suppl 1:S 168-77.
3. Wagner KS, White JM, Lucenko I, Mercer D, Crowcroft NS, Neal S, et al. Diphtheria in the postepidemic period, Europe, 2000-2009. Emerg Infect Dis. 2012;18(2):217-25. http://dx.doi.org/10.3201/eid1802.110987
4. World Health Organization (WHO). Immunization surveillance, assessment and monitoring. Last updated 27 Feb 2014. Geneva: WHO. [Accessed 10 Oct 2013]. Available from:http://www.who.int/immunization_monitoring/diseases/diphteria/en/index.html
5. European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report 2013. Stockholm: ECDC; 2013. [Accessed 10 June 2014]. Available from:http://www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=989
6. Dorella FA, Pacheco LG, Oliveira SC, Miyoshi A, Azevedo V. Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet Res. 2006;37(2):201-18. http://dx.doi.org/10.1051/vetres:2005056
7. Wagner KS, White JM, Neal S, Crowcroft NS, Kuprevičiene N, Paberza R, et al. Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007-2008: a multicentre European study. Clin Microbiol Infect. 2011;17(4):519-25. http://dx.doi.org/10.1111/j.1469-0691.2010.03269.x
8. Behring E, Kitasato S. Über das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren, 1890 [The mechanism of diphtheria immunity and tetanus immunity in animals. 1890]. Mol Immunol. 1991;28(12):1317, 1319-20. German.
9. Schwartz RS. Paul Ehrlich's magic bullets. N Engl J Med. 2004;350(11):1079-80. http://dx.doi.org/10.1056/NEJMp048021
10. Park WH, Atkinson JP. The relation of the toxicity of diphtheria toxin to its neutralizing value upon antitoxin at different stages in the growth of culture. J Exp Med. 1898;3(4-5):513-32. http://dx.doi.org/10.1084/jem.3.4-5.513
11. Linton DS. Emil von Behring: Infectious Disease, Immunology, Serum Therapy. Philadelphia: American Philosophical Society, 2005.
12. Casadevall A, Dadachova E, Pirofski LA. Passive antibody therapy for infectious diseases. Nat Rev Microbiol. 2004;2(9):695-703. http://dx.doi.org/10.1038/nrmicro974
13. World Health Organization (WHO). WHO Model Lists of Essential Medicines. Geneva: WHO. [Accessed 10 Oct 2013]. Available from: http://www.who.int/medicines/publications/essentialmedicines/en/
14. World Health Organization (WHO). Essential medicines. [Accessed 10 Oct 2013]. Available from:http://www.who.int/medicines/services/essmedicines_def/en/index.html
15. Begg, N. Manual for the Management and Control of Diphtheria in the European Region. Expanded Programme on Immunization. Copenhagen: WHO; 1994
16. Logina I, Donaghy M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1999;67(4):433-8. http://dx.doi.org/10.1136/jnnp.67.4.433
17. Wilde H, Thipkong P, Sitprija V, Chaiyabutr N. Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis. Ann Intern Med. 1996;125(3):233-6. http://dx.doi.org/10.7326/0003-4819-125-3-199608010-00012
18. From the Centers for Disease Control and Prevention. Availability of diphtheria antitoxin through an investigational new drug protocol. JAMA. 1997;277(21):1665. http://dx.doi.org/10.1001/jama.1997.03540450021010
19. Wagner KS, Stickings P, White JM, Neal S, Crowcroft NS, Sesardic D, et al. A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine. 2009;28(1):14-20. http://dx.doi.org/10.1016/j.vaccine.2009.09.094
20. Elek SD. The plate virulence test for diphtheria. J Clin Pathol. 1949;2(4):250-8. http://dx.doi.org/10.1136/jcp.2.4.250
21. Young PS, Smith DD. The detection of toxin production by Corynebacterium diphtheriae in diagnostic laboratories. Pathology. 1976;8(2):101-4. http://dx.doi.org/10.3109/00313027609094434
22. Engler KH, Glushkevich T, Mazurova IK, George RC, Efstratiou A. A modified Elek test for detection of toxigenic corynebacteria in the diagnostic laboratory. J Clin Microbiol. 1997;35(2):495-8.
23. Pallen MJ, Hay AJ, Puckey LH, Efstratiou A. Polymerase chain reaction for screening clinical isolates of corynebacteria for the production of diphtheria toxin. J Clin Pathol. 1994;47(4):353-6. http://dx.doi.org/10.1136/jcp.47.4.353
24. Hauser D, Popoff MR, Kiredjian M, Boquet P, Bimet F. Polymerase chain reaction assay for diagnosis of potentially toxinogenic Corynebacterium diphtheriae strains: correlation with ADP-ribosylation activity assay. J Clin Microbiol. 1993;31(10):2720-3.
25. Nakao H, Popovic T. Development of a direct PCR assay for detection of the diphtheria toxin gene. J Clin Microbiol. 1997;35(7):1651-5.
26. Schuhegger R, Lindermayer M, Kugler R, Heesemann J, Busch U, Sing A. Detection of toxigenic Corynebacterium diphtheriae and Corynebacterium ulcerans strains by a novel real-time PCR. J Clin Microbiol. 2008;46(8):2822-3. http://dx.doi.org/10.1128/JCM.01010-08
27. Sing A, Berger A, Schneider-Brachert W, Holzmann T, Reischl U. Rapid detection and molecular differentiation of toxigenic Corynebacterium diphtheriae and Corynebacterium ulcerans strains by LightCycler PCR. J Clin Microbiol. 2011;49(7):2485-9. http://dx.doi.org/10.1128/JCM.00452-11
28. Groman N, Cianciotto N, Bjorn M, Rabin M. Detection and expression of DNA homologous to the tox gene in nontoxigenic isolates of Corynebacterium diphtheriae. Infect Immun. 1983;42(1):48-56.
29. Sgouris JT, Volk VK, Angela F, Portwood L, Gottshall RY. Studies on diphtheria immune globulin prepared from outdated human blood. Vox Sang. 1969;16(6):491-5. http://dx.doi.org/10.1111/j.1423-0410.1969.tb04777.x
30. Hartman LJ. Bioavailability study of diphtheria immunoglobulin (human). Pathology. 1979;11(3):385-7. http://dx.doi.org/10.3109/00313027909059015
31. Bissumbhar B, Rakhmanova AG, Berbers GA, Iakolev A, Nosikova E, Melnick O, et al. Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations. Vaccine. 2004;22(15-16):1886-91. http://dx.doi.org/10.1016/j.vaccine.2003.11.006
32. Both L, Banyard AC, van Dolleweerd C, Wright E, Ma JK, Fooks AR. Monoclonal antibodies for prophylactic and therapeutic use against viral infections. Vaccine. 2013;31(12):1553-9. http://dx.doi.org/10.1016/j.vaccine.2013.01.025
33. Reichert JM. Marketed therapeutic antibodies compendium. MAbs. 2012;4(3):413-5. http://dx.doi.org/10.4161/mabs.19931
34. Danelli M das G, Teixeira LM, Formiga LC, Peralta JM. Protective monoclonal antibodies to diphtheria toxin. Mem Inst Oswaldo Cruz. 1991;86(2):265-7. http://dx.doi.org/10.1590/S0074-02761991000200017
35. Kakita M, Takahashi T, Komiya T, Iba Y, Tsuji T, Kurosawa Y, et al. Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin. Infect Immun. 2006;74(6):3682-3. http://dx.doi.org/10.1128/IAI.01731-05
36. Sevigny LM, Booth BJ, Rowley KJ, Leav BA, Cheslock PS, Garrity KA, et al. Identification of a Human Monoclonal Antibody to Replace Equine Diphtheria Anti-toxin for the Treatment of Diphtheria Intoxication. Infect Immun. 2013;81(11):3992-4000. http://dx.doi.org/10.1128/IAI.00462-13
37. Engler KH, Efstratiou A, Norn D, Kozlov RS, Selga I, Glushkevich TG, et al. Immunochromatographic strip test for rapid detection of diphtheria toxin: description and multicenter evaluation in areas of low and high prevalence of diphtheria. J Clin Microbiol. 2002;40(1):80-3. http://dx.doi.org/10.1128/JCM.40.1.80-83.2002
38. Hallas G, Harrison TG, Samuel D, Colman G. Detection of diphtheria toxin in culture supernates of Corynebacterium diphtheriae and C. ulcerans by immunoassay with monoclonal antibody. J Med Microbiol. 1990;32(4):247-53. http://dx.doi.org/10.1099/00222615-32-4-247
39. Engler KH, Efstratiou A. Rapid enzyme immunoassay for determination of toxigenicity among clinical isolates of corynebacteria. J Clin Microbiol. 2000;38(4):1385-9.